From the Archives of the AFIP - Islet Cell Tumors of the Pancreas: Clinical, Radiologic, and Pathologic Correlation in Diagnosis and Localization

Radiographics

Volumn 17, Issue 2, 1997, Pages 453-472

  Buetow, Peter C ^a,b   Miller, Donald L ^b,c   Parrino, Tremont V ^b,c   Buck, James L ^d  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Pancreas, neoplasms, 770.3124, 770.3191, 770.329

Indexed keywords

ADULT; AGED; ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; PANCREAS ISLET CELL TUMOR; PANCREAS TUMOR; PATHOLOGY; RADIOGRAPHY;

ADENOMA, ISLET CELL; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS;

EID: 0031084908     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiographics.17.2.9084084     Document Type: Article

References (66)

1. Freisen SR. Tumors of the endocrine pancreas. N Engl J Med 1982; 306:580-590.
2. Solcia E, Sessa F, Findi G. Classification and histogenesis of gastroenteropancreatic endocrine tumors. Eur J Clin Invest 1990; 20:572-596.
3. Buetow PC, Parrino TV, Buck JL, et al. Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. AJR 1995; 165:1175-1179.
4. Miller DL. Islet cell tumors of the pancreas: diagnosis and localization. In: Freeny PC, Stevenson GW, eds. Margulis and Burhenne's alimentary tract radiology. 5th ed. Chicago, Ill: Mosby-Year Book, 1994; 1167-1196.
5. Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955; 142:709-719.
6. Solcia E, Sessa F, Rindl G, Bonato M, Capella C. Pancreatic endocrine tumors: non-functioning tumors and tumors with uncommon function. In: Dayal Y, ed. Endocrine pathology of the gut and pancreas. Boca Raton, Fla: CRC, 1991; 105-131.
7. Watson RGP, Johnston CF, O'Hare NMT. The frequency of gastrointestinal endocrine tumors in a well-defined population: Northern Ireland 1970-1985. Q J Med 1989; 72:647-657.
8. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma: incidence, recurrence, and long-term survival of patients - a 60-year study. Mayo Clin Proc 1991; 66:711-719.
9. Service FJ. Hypoglycemic disorders. N Engl J Med 1995; 332:1144-1152.
10. Townsend CM, Thompson JC. Gastrinoma. Semin Surg Oncol 1990; 6:91-101.
11. Wolfe MM, Jensen RT. Zollinger-Ellison syndrome: current concepts in diagnosis and management. N Engl J Med 1987; 317:1200-1209.
12. Edney JA, Hoffman S, Thompson JS, Kessinger A. Glucagonoma syndrome is an underdiagnosed clinical entity. Am J Surg 1987; 82:68-74.
13. Dayal Y, Ganda OP. Somatostatin-producing tumors. In: Dayal Y, ed. Endocrine pathology of the gut and pancreas. Boca Raton, Fla: CRC, 1991; 160-182.
14. Krejs GS. Vipoma syndrome. Am J Med 1987; 82:37-47.
15. Doppman JL, Loughlin T, Miller DL. Identification of ACTH-producing intrathoracic tumors by measuring ACTH levels in aspirated specimens. Radiology 1987; 163:501-503.
16. Doppman JL, Travis WD, Nieman L. Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology 1989; 172:415-420.
17. Skogseid B, Larsson C, Oberg K. Genetic and clinical characteristics of multiple endocrine neoplasia type I. Acta Oncol 1991; 30:485-495.
18. Lamers CBNW. Gastrinoma in multiple endocrine neoplasia type 1. Acta Oncol 1991; 30: 349-360.
19. Doppman JL. The search for occult ectopic ACTH-producing tumors. Endocrinology 1992; 2:241-246.
20. Kloppel G, Heitz PU. Pancreatic endocrine tumors. Pathol Res Pract 1988; 183:155-172.
21. Oertel JE, Oertel YC, Heffess CS. The pancreas. In: Sternberg SS, ed. Diagnostic surgical pathology. New York, NY: Raven, 1989; 1088-1161.
22. Wynick D, Williams SJ, Bloom SR. Symptomatic secondary hormone syndromes in patients with malignant pancreatic endocrine tumors. N Engl J Med 1988; 319:605-607.
23. Farley DR, van Heerden JA, Grant CS, Thompson GB. Extrapancreatic gastrinomas: surgical experience. Arch Surg 1994; 129:506-512.
24. Gunther RW, Klose KJ, Ruckert K, Beyer J, Kuhn FP. Localization of small islet cell tumors: preoperative and intraoperative ultrasound, computed tomography, arteriography, digital subtraction angiography, and pancreatic venous sampling. Gastrointest Radiol 1985; 10: 145-152.
25. Fedorak IJ, Ko TC, Gordon D, Flisak M, Prinz RA. Localization of islet cell tumors of the pancreas: a review of current techniques. Surgery 1993; 113:242-249.
26. Hammond PJ, Jackson JA, Gloom SR. Localization of pancreatic endocrine tumours. Clin Endocrinol 1994; 40:3-14.
27. Rothmund M. Localization of endocrine pancreatic tumours. Br J Surg 1994; 81:164-166.
28. Pisegna JR, Doppman JL, Norton JA, Metz DC, Jensen RT. Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome. Dig Dis Sci 1993; 38: 1318-1328.
29. Müller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopie US, CT, and MR imaging. Radiology 1994; 190:745-751.
30. Reubi JC, Kvols LK, Waser B. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990; 50:5969-5977.
31. Virgolini L, Raderer M, Kurtaran A. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 1994; 331: 1116-1121.
32. Kvols LK, Brown ML, O'Connor MK. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. Radiology 1993; 187:129-133.
33. Scherubl H, Bader M, Fett U. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology 1993; 105:1705-1709.
34. Weinel RJ, Neuhaus C, Stapp J. Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy with octreotide. Q J Med 1994; 87:83-88.
35. Kvols LK. Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors (editorial). Gastroenterology 1993; 105:1909-1911.
36. Palazzo L, Roseau G, Salmeron M. Endoscopic ultrasonography in the preoperative localization of pancreatic endocrine tumors. Endoscopy 1992; 24:350-353.
37. Galiber AK, Reading CC, Charboneau JW. Localization of pancreatic insulinoma: comparison of pre-and intraoperative US with CT and angiography. Radiology 1988; 166:405-408.
38. Doherty GM, Doppman JL, Shawker TH. Results of a prospective strategy to diagnose, localize, and resect insulinomas. Surgery 1991; 110:989-996.
39. Gianello P, Gigot JF, Berthet F. Pre-and intra-operative localization of insulinomas: report of 22 observations. World J Surg 1988; 12:389-397.
40. Grant CS, van Heerden J, Charboneau JW, James EM, Reading CC. Insulinoma: the value of intraoperative ultrasonography. Arch Surg 1988; 123:843-848.
41. Tjon A, Tham RTO, Falke THM, Jansen JBMJ, Lamers CBHW. CT and MR imaging of advanced Zollinger-Ellison syndrome. J Comput Assist Tomogr 1989; 13:821-828.
42. Van Hoe L, Gryspeerdt S, Marchal G, Baert AL, Mertens L. Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. AJR 1995; 165:1437-1439.
43. Ahlstrom H, Magnusson A, Grama D, Eriksson B, Oberg K, Lorelius L. Preoperative localization of endocrine pancreatic tumours by intra-arterial dynamic computed tomography. Acta Radiol 1990; 31:171-175.
44. Bressler EL, Alpern MB, Glazer GM, Francis IR, Ensminger WD. Hypervascular hepatic metastases: CT evaluation. Radiology 1987; 162: 49-51.
45. Chomyn JJ, Stamm ER, Thickman D. CT of melanoma liver metastases: is the examination without contrast media superfluous? J Comput Assist Tomogr 1992; 16:568-571.
46. Patten RM, Byun JY, Freeny PC. CT of hypervascular hepatic tumors: are unenhanced scans necessary for diagnosis? AJR 1993; 161:979-984.
47. Smelka RC, Ascher SM. MR imaging of the pancreas. Radiology 1993; 188:593-602.
48. Smelka RC, Cumming MJ, Shoenut JP. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology 1993; 186:799-802.
49. Doppman JL, Shawker TH, Miller DL. Localization of islet cell tumors. Gastroenterol Clin North Am 1989; 18:793-804.
50. Lamberts SWJ, Hofland LJ, de Herder WW, Kwekkeboom DJ, Reubi JC, Krenning EP. Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy. Neuroendocrinology 1993; 14:27-55.
51. van Eyck CHJ, Bruining HA, Reubi J. Use of isotope-labelled somatostatin analogs for visualization of islet cell tumors. World J Surg 1993; 17:444-447.
52. Gibril F, Reynolds JC, Doppman JL, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas - a prospective study. Ann Intern Med 1996; 125:26-34.
53. Andersson T, Eriksson B, Hemmingsson A, Lindgren PG, Oberg K. Angiography, computed tomography, magnetic resonance imaging, and ultrasonography in detection of liver metastases from endocrine gastrointestinal tumours. Acta Radiol 1987; 28:535-539.
54. Stadnik T, Stevenaert A, Beckers A, Luypaert R, Buisseret T, Osteaux M. Pituitary microadenomas: diagnosis with two-and three-dimensional MR imaging at 1.5 T before and after injection of gadolinium. Radiology 1990; 176:419-428.
55. Imamura M, Takahashi K, Adachi H. Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 1987; 205:230-239.
56. Imamura M, Takahashi K. Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome. World J Surg 1993; 17:433-438.
57. Thom AK, Norton JA, Doppman JL, Miller DL, Chang R, Jensen RT. Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas. Surgery 1992; 112:1002-1009.
58. Doppman JL, Miller DL, Chang R, Gorden P, Eastman RC, Norton JA. Intraarterial stimulation test for detection of insulinomas. World J Surg 1993; 17:439-443.
59. Brunt LM, Veldhuis JD, Dilley WG. Stimulation of insulin secretion by a rapid intravenous calcium infusion in patients with B-cell neoplasms of the pancreas. J Clin Endocrinol Metab 1986; 62:210-216.
60. Kent RB, van Heerden, Weiland LH. Non-functioning islet cell tumors. Ann Surg 1981; 193:185-190.
61. Thompson GB, van Heerden JA, Grant CS. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery 1988; 104:1011-1017.
62. Klein KA, Stephens SH, Welch TJ. Imaging of metastatic disease to the pancreas (abstr). Radiology 1995; 197(P):501.
63. Buetow PC, Buck JL, Pantongrag-Brown L, Beck KG, Ros PR, Adair CF. Solid and papillary epithelial neoplasm of the pancreas: imaging-pathologic correlation in 56 cases. Radiology 1996; 199:707-711.
64. Gower WRJ, Fabri PJ. Endocrine neoplasms (non-gastrin) of the pancreas. Semin Surg Oncol 1990; 6:98-108.
65. Miller DL. Endocrine angiography and venous sampling. Radiol Clin North Am 1993; 31: 1051-1067.
66. Bakker WH, Krenning EP, Breeman W. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nucl Med 1991; 32:1184-1190.